Showing results (581-590 of 617) with videos related to
Sort By:
Pageof 62
Gynecologic Oncology|June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?Rachana Shah, Caihong Xia, Mark Krailo, et al.Journal of the National Cancer Institute|November 2, 2006
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancerCharles N Landen, Chunhua Lu, Liz Y Han, et al.Cancer Research|September 5, 2006
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinomaLiz Y Han, Charles N Landen, Jose G Trevino, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.Cancer|November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancerEmily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.Gynecologic Oncology|February 1, 2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutationsRobin A Lacour, Shannon N Westin, Larissa A Meyer, et al.Rheumatology and Therapy|November 13, 2022
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims DatabasesClaudia A Salinas, Anthony Louder, Jennifer Polinski, et al.Cancer Biology & Therapy|October 16, 2010
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M Merritt, Aparna A Kamat, Jee-Young Hwang, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancerJonathan A Ledermann, Christian Marth, Mark S Carey, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancerRachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.Pageof 62